Takeuchi, T., McInnes, I. B., Taylor, P. C., Fleischmann, R. M., Strand, V., Weinblatt, M. E., . . . Rayner, K. Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: Long-term extension of three phase 3 randomised trials (contRAst X). BMJ Publishing Group.
Chicago Style (17th ed.) CitationTakeuchi, Tsutomu, et al. Long-term Safety and Efficacy of Anti-GM-CSF Otilimab in Patients with Rheumatoid Arthritis: Long-term Extension of Three Phase 3 Randomised Trials (contRAst X). BMJ Publishing Group.
MLA (9th ed.) CitationTakeuchi, Tsutomu, et al. Long-term Safety and Efficacy of Anti-GM-CSF Otilimab in Patients with Rheumatoid Arthritis: Long-term Extension of Three Phase 3 Randomised Trials (contRAst X). BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.